nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—BCHE—malignant glioma	0.822	1	CbGaD
Pyridostigmine—CYP3A4—Temozolomide—malignant glioma	0.116	1	CbGbCtD
Pyridostigmine—Rivastigmine—BCHE—malignant glioma	0.00331	0.5	CrCbGaD
Pyridostigmine—Neostigmine—BCHE—malignant glioma	0.00331	0.5	CrCbGaD
Pyridostigmine—Abnormal behaviour—Temozolomide—malignant glioma	0.00281	0.0893	CcSEcCtD
Pyridostigmine—ACHE—Biogenic Amine Synthesis—ASMT—malignant glioma	0.0023	0.0966	CbGpPWpGaD
Pyridostigmine—Faecal incontinence—Carmustine—malignant glioma	0.00215	0.0682	CcSEcCtD
Pyridostigmine—Faecal incontinence—Temozolomide—malignant glioma	0.00208	0.0659	CcSEcCtD
Pyridostigmine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—malignant glioma	0.00165	0.0695	CbGpPWpGaD
Pyridostigmine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—malignant glioma	0.00155	0.0653	CbGpPWpGaD
Pyridostigmine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—malignant glioma	0.00139	0.0583	CbGpPWpGaD
Pyridostigmine—Neck pain—Carmustine—malignant glioma	0.0011	0.0348	CcSEcCtD
Pyridostigmine—Urinary incontinence—Carmustine—malignant glioma	0.00105	0.0332	CcSEcCtD
Pyridostigmine—Urinary incontinence—Temozolomide—malignant glioma	0.00101	0.0321	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Carmustine—malignant glioma	0.000909	0.0289	CcSEcCtD
Pyridostigmine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—BCHE—malignant glioma	0.000904	0.038	CbGpPWpGaD
Pyridostigmine—Thrombophlebitis—Temozolomide—malignant glioma	0.000879	0.0279	CcSEcCtD
Pyridostigmine—Eye pain—Carmustine—malignant glioma	0.000872	0.0277	CcSEcCtD
Pyridostigmine—Eye pain—Temozolomide—malignant glioma	0.000842	0.0267	CcSEcCtD
Pyridostigmine—ACHE—Synthesis of PC—BCHE—malignant glioma	0.000827	0.0348	CbGpPWpGaD
Pyridostigmine—Dry skin—Temozolomide—malignant glioma	0.000697	0.0221	CcSEcCtD
Pyridostigmine—Abdominal distension—Temozolomide—malignant glioma	0.000662	0.021	CcSEcCtD
Pyridostigmine—Sweating increased—Temozolomide—malignant glioma	0.00064	0.0203	CcSEcCtD
Pyridostigmine—Bronchitis—Temozolomide—malignant glioma	0.000632	0.0201	CcSEcCtD
Pyridostigmine—Pollakiuria—Temozolomide—malignant glioma	0.000607	0.0193	CcSEcCtD
Pyridostigmine—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.000607	0.0255	CbGpPWpGaD
Pyridostigmine—Hypoaesthesia—Carmustine—malignant glioma	0.000542	0.0172	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Temozolomide—malignant glioma	0.000523	0.0166	CcSEcCtD
Pyridostigmine—ACHE—Monoamine Transport—SLC6A3—malignant glioma	0.000513	0.0216	CbGpPWpGaD
Pyridostigmine—BCHE—Irinotecan Pathway—APC—malignant glioma	0.000512	0.0215	CbGpPWpGaD
Pyridostigmine—Alopecia—Carmustine—malignant glioma	0.000481	0.0153	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—NF1—malignant glioma	0.000474	0.0199	CbGpPWpGaD
Pyridostigmine—Alopecia—Temozolomide—malignant glioma	0.000465	0.0148	CcSEcCtD
Pyridostigmine—Agitation—Carmustine—malignant glioma	0.000436	0.0138	CcSEcCtD
Pyridostigmine—Agitation—Temozolomide—malignant glioma	0.000421	0.0134	CcSEcCtD
Pyridostigmine—Vertigo—Temozolomide—malignant glioma	0.000411	0.0131	CcSEcCtD
Pyridostigmine—Convulsion—Carmustine—malignant glioma	0.000411	0.013	CcSEcCtD
Pyridostigmine—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00041	0.0173	CbGpPWpGaD
Pyridostigmine—Myalgia—Carmustine—malignant glioma	0.000403	0.0128	CcSEcCtD
Pyridostigmine—Convulsion—Temozolomide—malignant glioma	0.000397	0.0126	CcSEcCtD
Pyridostigmine—Confusional state—Carmustine—malignant glioma	0.00039	0.0124	CcSEcCtD
Pyridostigmine—Myalgia—Temozolomide—malignant glioma	0.00039	0.0124	CcSEcCtD
Pyridostigmine—Confusional state—Temozolomide—malignant glioma	0.000377	0.012	CcSEcCtD
Pyridostigmine—Hypotension—Carmustine—malignant glioma	0.000361	0.0115	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Temozolomide—malignant glioma	0.000361	0.0115	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000352	0.0112	CcSEcCtD
Pyridostigmine—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.000349	0.0147	CbGpPWpGaD
Pyridostigmine—Paraesthesia—Carmustine—malignant glioma	0.000347	0.011	CcSEcCtD
Pyridostigmine—Somnolence—Carmustine—malignant glioma	0.000344	0.0109	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000341	0.0108	CcSEcCtD
Pyridostigmine—Paraesthesia—Temozolomide—malignant glioma	0.000336	0.0107	CcSEcCtD
Pyridostigmine—Somnolence—Temozolomide—malignant glioma	0.000332	0.0106	CcSEcCtD
Pyridostigmine—Feeling abnormal—Carmustine—malignant glioma	0.000319	0.0101	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Carmustine—malignant glioma	0.000316	0.01	CcSEcCtD
Pyridostigmine—Feeling abnormal—Temozolomide—malignant glioma	0.000308	0.00978	CcSEcCtD
Pyridostigmine—Abdominal pain—Carmustine—malignant glioma	0.000306	0.00971	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000306	0.0097	CcSEcCtD
Pyridostigmine—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000302	0.0127	CbGpPWpGaD
Pyridostigmine—Urticaria—Temozolomide—malignant glioma	0.000297	0.00943	CcSEcCtD
Pyridostigmine—Abdominal pain—Temozolomide—malignant glioma	0.000295	0.00938	CcSEcCtD
Pyridostigmine—Hypersensitivity—Carmustine—malignant glioma	0.000285	0.00905	CcSEcCtD
Pyridostigmine—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000283	0.0119	CbGpPWpGaD
Pyridostigmine—Asthenia—Carmustine—malignant glioma	0.000278	0.00881	CcSEcCtD
Pyridostigmine—Hypersensitivity—Temozolomide—malignant glioma	0.000275	0.00874	CcSEcCtD
Pyridostigmine—Asthenia—Temozolomide—malignant glioma	0.000268	0.00851	CcSEcCtD
Pyridostigmine—Diarrhoea—Carmustine—malignant glioma	0.000265	0.0084	CcSEcCtD
Pyridostigmine—Diarrhoea—Temozolomide—malignant glioma	0.000256	0.00812	CcSEcCtD
Pyridostigmine—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000251	0.0106	CbGpPWpGaD
Pyridostigmine—ACHE—Peptide hormone metabolism—BCHE—malignant glioma	0.00025	0.0105	CbGpPWpGaD
Pyridostigmine—Vomiting—Carmustine—malignant glioma	0.000246	0.00781	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—HES1—malignant glioma	0.000246	0.0103	CbGpPWpGaD
Pyridostigmine—Rash—Carmustine—malignant glioma	0.000244	0.00774	CcSEcCtD
Pyridostigmine—Dermatitis—Carmustine—malignant glioma	0.000244	0.00774	CcSEcCtD
Pyridostigmine—ACHE—Glycerophospholipid biosynthesis—BCHE—malignant glioma	0.000243	0.0102	CbGpPWpGaD
Pyridostigmine—Headache—Carmustine—malignant glioma	0.000242	0.00769	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00024	0.0101	CbGpPWpGaD
Pyridostigmine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000239	0.0101	CbGpPWpGaD
Pyridostigmine—Vomiting—Temozolomide—malignant glioma	0.000238	0.00755	CcSEcCtD
Pyridostigmine—Rash—Temozolomide—malignant glioma	0.000236	0.00748	CcSEcCtD
Pyridostigmine—Dermatitis—Temozolomide—malignant glioma	0.000235	0.00748	CcSEcCtD
Pyridostigmine—Headache—Temozolomide—malignant glioma	0.000234	0.00743	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—PDGFRA—malignant glioma	0.000234	0.00984	CbGpPWpGaD
Pyridostigmine—Nausea—Carmustine—malignant glioma	0.00023	0.00729	CcSEcCtD
Pyridostigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000228	0.00959	CbGpPWpGaD
Pyridostigmine—Nausea—Temozolomide—malignant glioma	0.000222	0.00705	CcSEcCtD
Pyridostigmine—ACHE—Monoamine Transport—IL1B—malignant glioma	0.000209	0.00879	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000182	0.00764	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000172	0.00725	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—BCHE—malignant glioma	0.000169	0.00712	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—MMP2—malignant glioma	0.000161	0.00676	CbGpPWpGaD
Pyridostigmine—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000155	0.00653	CbGpPWpGaD
Pyridostigmine—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000154	0.00647	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000154	0.00646	CbGpPWpGaD
Pyridostigmine—ACHE—Monoamine Transport—TNF—malignant glioma	0.000152	0.00638	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—BCL2—malignant glioma	0.000145	0.0061	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000145	0.00609	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—IFNG—malignant glioma	0.000144	0.00604	CbGpPWpGaD
Pyridostigmine—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000143	0.00601	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00014	0.00591	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—CXCL8—malignant glioma	0.000134	0.00562	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000126	0.00529	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000125	0.00528	CbGpPWpGaD
Pyridostigmine—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000124	0.00521	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000118	0.00498	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000117	0.00493	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—RTEL1—malignant glioma	0.000114	0.0048	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000109	0.00459	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000106	0.00444	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—RTEL1—malignant glioma	0.000102	0.00429	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000102	0.00428	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000102	0.00427	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000101	0.00423	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—BCHE—malignant glioma	9.64e-05	0.00406	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—XBP1—malignant glioma	9.2e-05	0.00387	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—PIK3CG—malignant glioma	9.19e-05	0.00387	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	9.14e-05	0.00384	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—SLC6A3—malignant glioma	9.07e-05	0.00381	CbGpPWpGaD
Pyridostigmine—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	8.47e-05	0.00356	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—XBP1—malignant glioma	8.21e-05	0.00345	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—PIK3CG—malignant glioma	8.2e-05	0.00345	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	8.17e-05	0.00344	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.16e-05	0.00343	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—SLC6A3—malignant glioma	8.09e-05	0.0034	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—PIK3CD—malignant glioma	8.08e-05	0.0034	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.9e-05	0.00332	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	7.71e-05	0.00324	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	7.32e-05	0.00308	CbGpPWpGaD
Pyridostigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	7.3e-05	0.00307	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.28e-05	0.00306	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—PIK3CD—malignant glioma	7.21e-05	0.00303	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	7.09e-05	0.00298	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.05e-05	0.00296	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—PIK3CB—malignant glioma	7.04e-05	0.00296	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	7.01e-05	0.00295	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—SPHK1—malignant glioma	6.82e-05	0.00287	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—COX8A—malignant glioma	6.56e-05	0.00276	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—BRAF—malignant glioma	6.42e-05	0.0027	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—PIK3CB—malignant glioma	6.28e-05	0.00264	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	6.23e-05	0.00262	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	6.15e-05	0.00259	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—SPHK1—malignant glioma	6.09e-05	0.00256	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—PTEN—malignant glioma	6.09e-05	0.00256	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	5.97e-05	0.00251	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.86e-05	0.00247	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—COX8A—malignant glioma	5.85e-05	0.00246	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—BRAF—malignant glioma	5.73e-05	0.00241	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	5.67e-05	0.00238	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	5.58e-05	0.00235	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ASMT—malignant glioma	5.58e-05	0.00235	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	5.56e-05	0.00234	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	5.5e-05	0.00231	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.45e-05	0.00229	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—PTEN—malignant glioma	5.43e-05	0.00228	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	5.4e-05	0.00227	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	5.38e-05	0.00226	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—MDM2—malignant glioma	5.38e-05	0.00226	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—RAF1—malignant glioma	5.36e-05	0.00226	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	5.33e-05	0.00224	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—BCAN—malignant glioma	5.24e-05	0.00221	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.23e-05	0.0022	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	5e-05	0.0021	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ASMT—malignant glioma	4.98e-05	0.00209	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—BRAF—malignant glioma	4.92e-05	0.00207	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—MDM2—malignant glioma	4.8e-05	0.00202	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—RAF1—malignant glioma	4.78e-05	0.00201	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—BCHE—malignant glioma	4.71e-05	0.00198	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.69e-05	0.00197	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—BCAN—malignant glioma	4.68e-05	0.00197	CbGpPWpGaD
Pyridostigmine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	4.68e-05	0.00197	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—FBXW7—malignant glioma	4.63e-05	0.00195	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—BRAF—malignant glioma	4.39e-05	0.00185	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	4.37e-05	0.00184	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—PIK3CA—malignant glioma	4.29e-05	0.00181	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	4.24e-05	0.00178	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—IDH2—malignant glioma	4.23e-05	0.00178	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—FBXW7—malignant glioma	4.13e-05	0.00174	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—MDM2—malignant glioma	4.12e-05	0.00173	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—RAF1—malignant glioma	4.11e-05	0.00173	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	4.1e-05	0.00172	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.99e-05	0.00168	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP2B6—malignant glioma	3.97e-05	0.00167	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.9e-05	0.00164	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—PIK3CA—malignant glioma	3.83e-05	0.00161	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.82e-05	0.0016	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—IDH2—malignant glioma	3.77e-05	0.00159	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—MDM2—malignant glioma	3.68e-05	0.00155	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—RAF1—malignant glioma	3.67e-05	0.00154	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—IDH1—malignant glioma	3.64e-05	0.00153	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.63e-05	0.00153	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.6e-05	0.00152	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.56e-05	0.0015	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP2B6—malignant glioma	3.55e-05	0.00149	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SPHK1—malignant glioma	3.52e-05	0.00148	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP2C18—malignant glioma	3.45e-05	0.00145	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.31e-05	0.00139	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.25e-05	0.00137	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—IDH1—malignant glioma	3.24e-05	0.00136	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.2e-05	0.00135	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SPHK1—malignant glioma	3.14e-05	0.00132	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP2C18—malignant glioma	3.07e-05	0.00129	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—RTEL1—malignant glioma	3.06e-05	0.00129	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.03e-05	0.00127	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	2.99e-05	0.00126	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.96e-05	0.00124	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.9e-05	0.00122	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.86e-05	0.0012	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTT1—malignant glioma	2.79e-05	0.00117	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.7e-05	0.00114	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—F2—malignant glioma	2.67e-05	0.00112	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.64e-05	0.00111	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PTGS1—malignant glioma	2.61e-05	0.0011	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.6e-05	0.00109	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.55e-05	0.00107	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTT1—malignant glioma	2.49e-05	0.00105	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—BCHE—malignant glioma	2.43e-05	0.00102	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SLC5A5—malignant glioma	2.4e-05	0.00101	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—F2—malignant glioma	2.38e-05	0.001	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PTGS1—malignant glioma	2.33e-05	0.00098	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.32e-05	0.000976	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.27e-05	0.000954	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—MMP2—malignant glioma	2.27e-05	0.000953	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.25e-05	0.000945	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SLC5A5—malignant glioma	2.14e-05	0.0009	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.02e-05	0.000851	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—MMP2—malignant glioma	2.02e-05	0.00085	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2e-05	0.000843	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.96e-05	0.000824	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTP1—malignant glioma	1.93e-05	0.000812	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—CXCL8—malignant glioma	1.88e-05	0.000792	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CAT—malignant glioma	1.88e-05	0.000791	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—NCOR1—malignant glioma	1.78e-05	0.000747	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—COX8A—malignant glioma	1.76e-05	0.00074	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.75e-05	0.000735	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTP1—malignant glioma	1.72e-05	0.000725	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—CXCL8—malignant glioma	1.68e-05	0.000707	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CAT—malignant glioma	1.68e-05	0.000705	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NCOR1—malignant glioma	1.58e-05	0.000666	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ASMT—malignant glioma	1.5e-05	0.000629	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CAV1—malignant glioma	1.45e-05	0.000609	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—BCAN—malignant glioma	1.41e-05	0.000592	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.38e-05	0.000582	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CG—malignant glioma	1.32e-05	0.000554	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CAV1—malignant glioma	1.29e-05	0.000543	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PPARG—malignant glioma	1.27e-05	0.000535	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.23e-05	0.000519	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CG—malignant glioma	1.18e-05	0.000495	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CD—malignant glioma	1.16e-05	0.000487	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PPARG—malignant glioma	1.14e-05	0.000477	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—IDH2—malignant glioma	1.13e-05	0.000477	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.07e-05	0.000448	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CD—malignant glioma	1.03e-05	0.000435	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CB—malignant glioma	1.01e-05	0.000425	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PTGS2—malignant glioma	1e-05	0.000421	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—IDH1—malignant glioma	9.75e-06	0.00041	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SPHK1—malignant glioma	9.43e-06	0.000397	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.24e-06	0.000389	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CB—malignant glioma	9.01e-06	0.000379	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PTGS2—malignant glioma	8.93e-06	0.000376	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PTEN—malignant glioma	8.73e-06	0.000367	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PTEN—malignant glioma	7.79e-06	0.000327	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTT1—malignant glioma	7.47e-06	0.000314	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PTGS1—malignant glioma	7e-06	0.000295	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—BCHE—malignant glioma	6.51e-06	0.000274	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.43e-06	0.00027	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CA—malignant glioma	6.16e-06	0.000259	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CA—malignant glioma	5.49e-06	0.000231	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTP1—malignant glioma	5.18e-06	0.000218	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CAT—malignant glioma	5.04e-06	0.000212	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—AKT1—malignant glioma	5.03e-06	0.000212	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NCOR1—malignant glioma	4.76e-06	0.0002	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—AKT1—malignant glioma	4.49e-06	0.000189	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CAV1—malignant glioma	3.88e-06	0.000163	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.54e-06	0.000149	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PPARG—malignant glioma	3.41e-06	0.000143	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.11e-06	0.000131	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.71e-06	0.000114	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.68e-06	0.000113	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PTEN—malignant glioma	2.34e-06	9.84e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.65e-06	6.94e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—AKT1—malignant glioma	1.35e-06	5.67e-05	CbGpPWpGaD
